Nanjing Vishee Medical Technology Co., Ltd (SHA:688580)

SHA:688580 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	872.69	1,023	1,068	1,155	1,248	1,366
Cash & Short-Term Investments	872.69	1,023	1,068	1,155	1,248	1,366
Cash Growth	-14.30%	-4.23%	-7.52%	-7.46%	-8.63%	-0.04%
Accounts Receivable	14.95	17.1	25.15	36.62	21.11	24.31
Other Receivables	3.66	26.14	23.84	16.7	10.74	11.27
Receivables	18.61	43.24	48.99	53.32	31.85	35.58
Inventory	46.78	42.21	38.74	39.92	34.84	30.44
Prepaid Expenses	-	1.23	1.22	0.62	0.79	0.36
Other Current Assets	36.14	5.78	6.17	5.98	3.61	1.98
Total Current Assets	974.22	1,115	1,163	1,255	1,319	1,434
Property, Plant & Equipment	444.27	497.8	410.11	321.53	172.54	100.26
Long-Term Investments	29.25	29.25	24.46	22.04	-	-
Goodwill	69.31	69.31	69.31	69.31	69.31	-
Other Intangible Assets	94.96	130.37	127.68	120.57	106.48	18.76
Long-Term Deferred Tax Assets	12.24	14.04	13.41	15.1	7.91	12.74
Long-Term Deferred Charges	27.67	1.21	2.07	1.25	2.63	0.77
Other Long-Term Assets	153.36	51.63	10.06	1.4	6.14	71.88
Total Assets	1,805	1,909	1,820	1,806	1,684	1,639

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	19.28	23.84	19.4	17.96	19.72	9.28
Accrued Expenses	8.37	31.98	28.84	32.24	35.92	26.6
Current Portion of Leases	0.16	0.82	0.75	-	1.19	1.18
Current Income Taxes Payable	11.4	8.77	3.86	10.81	4.63	16.23
Current Unearned Revenue	1.89	3.68	4.82	6.28	13.49	33.29
Other Current Liabilities	50.3	146.33	133.9	84.4	54.3	17.29
Total Current Liabilities	91.4	215.42	191.59	151.68	129.24	103.87
Long-Term Leases	0.11	0.24	0.9	-	-	1.81
Long-Term Deferred Tax Liabilities	0.31	0.35	0.42	0.48	0.55	-
Other Long-Term Liabilities	-	-	-	27.1	25.87	-
Total Liabilities	91.82	216	192.9	179.27	155.67	105.68

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	95.77	95.77	95.77	68.62	68.62	68.35
Additional Paid-In Capital	1,066	1,066	1,065	1,112	1,091	1,086
Retained Earnings	554.42	534.01	472.51	472.74	383.39	378.47
Treasury Stock	-2.43	-2.43	-5.77	-26.45	-14.87	-
Total Common Equity	1,713	1,693	1,627	1,627	1,529	1,533
Shareholders' Equity	1,713	1,693	1,627	1,627	1,529	1,533
Total Liabilities & Equity	1,805	1,909	1,820	1,806	1,684	1,639

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.27	1.05	1.65	-	1.19	2.99
Net Cash (Debt)	872.42	1,022	1,067	1,155	1,247	1,363
Net Cash Growth	-14.32%	-4.18%	-7.66%	-7.37%	-8.52%	-0.25%
Net Cash Per Share	9.11	10.66	11.19	12.07	13.03	14.20
Filing Date Shares Outstanding	95.71	95.71	95.71	95.37	95.62	95.69
Total Common Shares Outstanding	95.71	95.71	95.71	95.37	95.62	95.69
Working Capital	882.81	900.02	971.68	1,103	1,190	1,330
Book Value Per Share	17.90	17.69	17.00	17.06	15.99	16.02
Tangible Book Value	1,549	1,493	1,430	1,437	1,353	1,514
Tangible Book Value Per Share	16.19	15.60	14.95	15.07	14.15	15.83
Buildings	-	419.76	96.32	96.32	96.39	96.39
Machinery	-	54.31	50.15	46.52	38.08	22.81
Construction In Progress	-	96.66	319.83	224.86	70.44	2.51

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error